News
Stage 4 Mucosal Melanoma to No Evidence of Disease: Dane Thorp's Journey
By Renee Orcione, MRA Digital Engagement & Communications Manager | 26 June 2024 In Allies & Partnerships, Melanoma Stories, Prevention, Science, Treatment
“I can’t hide the fact that I had melanoma,” said Stage 4 mucosal melanoma survivor Dane Thorp. “And when I share my story with others, I always emphasize the importance of being your own advocate.”
What to Know About the Different Types of Cutaneous Melanoma
21 June 2024 In Allies & Partnerships, Prevention, Science, Treatment
Cutaneous melanoma is the most common form of melanoma, accounting for roughly 90% of all diagnoses. Cutaneous melanoma typically develops on skin that receives UV exposure. Other types of melanoma include acral, uveal, and mucosal melanoma – these are known as rare melanoma subtypes and are not believed to be...
AI and Melanoma: Innovation for the Future
17 June 2024 In Allies & Partnerships, Prevention, Science, Treatment
“Artificial intelligence (AI) is going to transform how we diagnose, treat, and eventually overcome melanoma,” says Dr. Veronica Rotemberg, Director, Dermatology Imaging Informatics Program at Memorial Sloan Kettering Cancer Center.
Melanoma Awareness Month 2024: In Case You Missed It
By Renee Orcione, MRA Digital Engagement & Communications Manager | 30 May 2024 In Allies & Partnerships, Events, Melanoma Stories, News, Prevention, Science, Treatment
Throughout the last 31 days, the entire melanoma community has come together to recognize Melanoma Awareness Month. The community heard from leading experts in the field, connected with other patient advocates, and spread awareness of melanoma and the importance of prevention, early detection, and the impact of research.
Reflecting on Melanoma Awareness Month and Understanding Your Risk for Melanoma
30 May 2024 In Allies & Partnerships, Prevention, Science
Melanoma Awareness Month serves as an important time to reflect on the impact that melanoma has on so many lives. It is also a time to raise awareness of its dangers, who may be at higher risk, and how to prevent and detect it.
Kelly McWhinney's Melanoma Journey of Perseverance and Perspective
By Renee Orcione, MRA Digital Engagement & Communications Manager | 13 May 2024 In Allies & Partnerships, Melanoma Stories, Prevention, Science, Treatment
In March of 2022, Kelly McWhinney was a busy mother to her one and two-year-old daughters Mia and Blakely. Life was as hectic as expected for the 27-year-old, but when she noticed that a mole on her back was suddenly changing, she decided to call her dermatologist.
Melanoma Research Alliance Announces $12.6 Million Investment in Cutting Edge Melanoma Research
1 May 2024 In Allies & Partnerships, News, Prevention, Science, Treatment
The Melanoma Research Alliance (MRA), the world’s leading non-profit funder of melanoma research, announced its $12.6 million commitment to fund melanoma research supporting more than 30 scientists at leading academic and medical institutions in the United States and across the globe. Melanoma, the deadliest form of skin cancer, remains a public...
Melanoma Awareness Month: Ways to Get Involved
By Renee Orcione, MRA Digital Engagement & Communications Manager | 29 April 2024 In Allies & Partnerships, Events, Melanoma Stories, News, Prevention, Science, Treatment
Melanoma Awareness Month, held each May, is an occasion to connect and be in community with others who have been touched by melanoma. With this month brings the opportunity to join forces with other melanoma advocates to raise awareness of melanoma research, the importance of early detection, and the many...
Why I Step – Jeff Heaser
By Renee Orcione, MRA Digital Engagement & Communications Manager | 18 April 2024 In Allies & Partnerships, Events, Melanoma Stories, Prevention, Science, Treatment
In the summer of 2017, Jeff Heaser's eldest son, Jake, received a devastating diagnosis: Stage 4 melanoma. Over the following several years to treat his melanoma, Jake underwent multiple surgeries, radiation treatment, BRAF targeted therapy, immunotherapy, and countless blood tests and scans through Vanderbilt-Ingram Cancer Center.
Neoadjuvant Therapy and the Melanoma Standard of Care: Where Does it Fit In?
15 April 2024 In Allies & Partnerships, Science, Treatment
The standard of care for patients with high-risk Stage 3 melanoma with active disease, palpable lymph nodes (lymph nodes that can be felt), or in-transit metastasis (cancer cells that have started to spread but have not yet reached the lymph nodes)1 is surgery followed by systemic treatment.